SOPHiA GENETICS Prices $50M Public Offering at $4.75/Share
SOPH has more than doubled off its 52-week low of $2.59 on elevated volume (12× avg).
Summary
SOPHiA GENETICS has priced its public offering of 10.5 million ordinary shares at $4.75 each, raising approximately $50 million for working capital and growth, an event met with a positive market response.
Key Events · Financing and Capital Events · SOPH
-
Public Offering Priced
SOPHiA GENETICS has finalized the pricing of its underwritten public offering, selling 10,526,000 ordinary shares at $4.75 per share. This follows a preliminary prospectus supplement filed on June 16, 2026.
-
Substantial Capital Raised
The offering is expected to generate approximately $50.0 million in gross proceeds, or $46.0 million net of underwriting discounts and estimated offering expenses, providing significant capital for the company.
-
Potential Dilution
The issuance of 10,526,000 new shares represents a notable increase in outstanding shares, potentially diluting existing shareholders by approximately 14.7% based on shares outstanding as of March 31, 2026.
-
Use of Proceeds
The net proceeds are intended for working capital and general corporate purposes, including research and development, expanding sales and marketing efforts, establishing new collaborations, and obtaining regulatory approvals.
Analysis · SOPH · Technology
This filing finalizes the terms and pricing of SOPHiA GENETICS' public offering, raising approximately $50 million through the sale of 10.5 million ordinary shares at $4.75 per share. While the offering is dilutive for existing shareholders, the successful securing of substantial capital for working capital, research and development, and strategic growth initiatives is a critical step for the company. The market's positive reaction, with shares advancing after the pricing announcement, indicates investor confidence in the company's ability to leverage these funds for future growth.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 36.4% of the 1070 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SOPH was trading at $5.25 on NASDAQ in the Technology sector, with a market capitalization of approximately $375.5M. The 52-week trading range was $2.59 to $5.70. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.